Advanced Search

 

Study ID Status Title Patient Level Data
114693 Completed Two part study to investigate pharmacokinetics (PK) & pharmacodynamics (PD) of SB-705498, TRPV1 antagonist, in cough. Part A: open label study in healthy subjects to determine exposure to SB-705498. Part B: double-blind, placebo controlled, cross over study to investigate effect of SB-705498 on capsaicin induced cough and 24 hour cough counts in cough patients Study Listed on ClinicalStudyDataRequest.com
114694 Completed An Open-label, Randomized, Single Dose, Two-Period Crossover study to Determine the Bioavailability of a Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0.2mg) Relative to Co-administration of Dutasteride 0.5mg capsules and Tamsulosin Hydrochloride 0.2mg Study Listed on ClinicalStudyDataRequest.com
114695 Completed Immunogenicity and safety of GlaxoSmithKline Biologicals’ (pre-) pandemic influenza vaccine Prepandrix™ in Korean subjects aged 18 to 60 years old
114700 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals' HPV-16/18 L1 AS04 vaccine when administered according to alternative 2-dose schedules in 9 - 14 year old females Study Listed on ClinicalStudyDataRequest.com
114703 Completed A randomized, open-label, 3-period crossover study in healthy subjects to determine the effect of particle size on the pharmacokinetics of single oral 100mg doses of GSK1278863A Study Listed on ClinicalStudyDataRequest.com
114728 Completed A multicenter, two part, randomized, parallel group, placebo and sitagliptin controlled study to evaluate the safety and efficacy of GSK256073 administered once or twice daily for 12 weeks in subjects with type 2 diabetes mellitus who are being treated with metformin Study Listed on ClinicalStudyDataRequest.com
114729 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers
114730 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
114731 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Cumulative Irritation Potential of Topically Applied Calcipotriene Foam, 0.005% in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114738 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Potential of Topically Applied EF Calcipotriene Foam, 0.005% to Induce Contact Sensitization in Healthy Volunteers Upon Exposure to Repeated Skin Patch Applications Study Listed on ClinicalStudyDataRequest.com
114739 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied EF Calcipotriene Foam, 0.005% in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114740 Completed A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Phototoxic Potential of Topically Applied EF Calcipotriene Foam, 0.005% in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114741 Completed A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267, versus Vehicle in Subjects with Plaque-type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114742 Completed A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety and Efficacy of Emulsion Formulation U0267 , versus Vehicle Foam in Subjects with Plaque-type Psoriasis Study Listed on ClinicalStudyDataRequest.com
114743 Completed A Multicenter, Randomized, Double-Blind Study of the Safety and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam In The Treatment Of Moderate Plaque-Type Scalp And Body Psoriasis Study Listed on ClinicalStudyDataRequest.com
114746 Completed A Phase 1b, multi-center, open-label, dose escalation study of GSK2256098 (FAK inhibitor) in combination with Trametinib (MEK inhibitor) in subjects with advanced solid tumors
114748 Completed A randomized, double blind, placebo-controlled three-way crossover study in mild asthmatics to evaluate the effect of smoking status on the attenuation by inhaled corticosteroids of the allergen-induced asthmatic response. Study Listed on ClinicalStudyDataRequest.com
114749 Completed A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
114764 Completed An observational study to determine the correlation between MAGE-A3, PRAME polymorphism and expression levels of MAGE-A3 and PRAME in NSCLC patients in Taiwan (NOT FINAL TITLE)
114769 Completed A Meta Analysis of malignancy serious adverse events in the ADOPT, 49653/048, and RECORD, 49653/231, studies, comparing metformin with rosiglitazone.
114777 Completed The prevalence of osteoporotic vertebral compression fractures (OVCF) in Korean post menopausal women
114778 Completed Immunogenicity and safety study of GSK Biologicals’ Boostrix™ vaccine using a new syringe presentation in healthy adolescents aged 10–15 years Study Listed on ClinicalStudyDataRequest.com
114782 Active, Not Recruiting Drug Use Investigation for VOLIBRIS® (ambrisentan) (Pulmonary arterial hypertension)
114784 Completed A Phase I Trial of GSK1120212 and GSK1120212 in Combination with Gemcitabine in Japanese Subjects with Solid Tumors
114790 Completed Risk of cancer in patients exposed to gabapentin in the GPRD

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.